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against receptors and enzymes. The immunosuppressant rapamycin can serve an entirely different
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activate enzyme activity inside the intact cell. A number of very recent developments such as pho-
toactivatable derivatives make rapamycin an even more attractive tool for basic science.
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Protein translocation is one of the key events that help regulate
cell functions. Among the most prominent examples are proteins
that enter or leave the nucleus or another organelle, often in a reg-
ulated fashion. By this means, different cellular compartments are
able to communicate and exchange material. In cytosolic signal
transduction networks, protein translocation from the cytosol to
internal membranes or the inner leaﬂet of the plasma membrane
represents a principal way of how signals may be dispersed with-
out the need to cross from one cellular compartment to another. In
fact, the shear concentration of signaling partners at a 2-dimen-
sional surface seems to be sufﬁcient to increase the local concen-
tration, resulting in efﬁcient interaction and signal transmission.
An example is the interaction of Akt and PDK1 (3-phosphoinositide
dependent protein kinase-1) which usually requires the transloca-
tion of both proteins to the plasma membrane [1]. As both Akt and
PDK1 bear PH domains that recognize the lipid second messenger
phosphatidylinositol 3,4,5-trisphosphate [PtdIns(3,4,5)P3], they
accumulate at the same membrane region, phosphorylate each
other and thereby fulﬁll the next signaling step within the net-
work. Interestingly, both molecules also phosphorylate and inter-
act with each other when artiﬁcially brought in close proximity
within the cytosol [1]. This means that the intrinsic activity of
the complex is at least partially independent from the membrane
but requires the small molecule switch, in this case the phosphoin-cal Societies. Published by Elsevierositide PtdIns(3,4,5)P3, to induce proximity. The change from the
3-dimensional space of the cytosol to the membrane surface re-
sults in a concentration effect of at least one order of magnitude,
although a true concentration is tough to determine at a mem-
brane. The residence of lipids in certain membrane compartments
leads to an even higher protein density, potentially up to a factor of
100. It remains the question, why the coincidental interaction of
two signaling molecules does not produce a signiﬁcant signal. In
most cases, a kiss-and-run interaction is simply not producing en-
ough molecular events (such as phosphorylation) to give rise to a
sustainable signal, which would be resistant to the opposing action
of the counteracting enzymes (such as ubiquitously distributed
phosphatases). As a result, the inner leaﬂet of the plasma mem-
brane and also organelle membranes may be considered distin-
guished cellular compartments, even if physical shielding is not
provided. When observed by realtime imaging, translocation of a
protein from the cytosol to a membrane seems to be very fast on
the timescale relevant for non-excitable mammalian cells. Usually,
translocation events are complete within a few seconds, which cor-
responds to one or two frames when observed in a standard live
cell imaging setup. From this, it becomes apparent, that transloca-
tion must be considered a very fast vehicle to alter intracellular
events. Most other techniques for manipulation are based on
changing protein numbers rather than localization. This includes
transfection/overexpression and RNAi methods that require 10–
72 h for showing an often incomplete effect, or various techniques
that speciﬁcally activate selective degradation of the protein of
interest [2,3]. The later shows signiﬁcant effects within tens of
minutes to hours [4]. Therefore, intracellular translocation isB.V. Open access under CC BY-NC-ND license.
2098 M. Putyrski, C. Schultz / FEBS Letters 586 (2012) 2097–2105signiﬁcantly faster in comparison and the time required for artiﬁ-
cially induced translocation by small molecules such as rapamycin
is most probably determined by the pace of cell entry of the chem-
ical dimerizer rather than the speed of protein translocation.
2. The principle of induced translocation
As just mentioned, some small molecules are able to induce
protein–protein interaction. Collectively they are called ‘chemical
inducers of dimerization’ or CIDs. The most prominent feature of
CIDs is the ability to bind two proteins/protein domains simulta-
neously. If these proteins are of the same kind, we speak of homo-
dimerizers. If two different proteins are bound, the compounds are
named heterodimerizers. Surprisingly and unfortunately, the num-
ber of known chemical dimerizers is quite limited. Historically,
studies on the mechanism of action of immunosuppressants
FK506 and cyclosporin A (CsA) paved the path to the development
of the CID technology [5]. As a result, FK1012, a synthetic dimer of
FK506, gave rise to an entire family of chemical homodimerizers
used to connect two copies of FK506 binding protein with a mass
of 12 kDa (FKBP12), a ubiquitous prolyl cis–trans isomerase [6].
Importantly, the development of chemical heterodimerizers has
been heavily inﬂuenced by the discovery of the mechanism of ac-
tion of rapamycin, yet another immunosuppressive drug, which
potently inhibits the protein kinase TOR (target of rapamycin),
more exactly the TORC1 multiprotein complex (TOR complex 1),
of which TOR is one of the constituents [7]. The mechanism of
TORC1 inhibition by rapamycin is of particular importance. Within
a cell, the rapamycin molecule ﬁrst binds to FKBP12 and only then
the FKBP12–rapamycin complex binds to TOR (precisely to the FRB
(FKBP and rapamycin binding) domain of the kinase), rendering
TORC1 enzymatically inactive (Fig. 1) [8,9]. Therefore, two proteins
genetically fused to FKBP12 and FRB, respectively, are brought into
close proximity in the presence of rapamycin. Since the ﬁrst report
describing the application of such a strategy in cells for inducing
gene expression [10], rapamycin and its derivatives have clearly
dominated the ﬁeld of small molecule heterodimerizers. Applica-
tions range from using rapamycin-inducible FKBP/FRB interactions
in proof-of-concept experiments when designing new methods for
monitoring protein–protein interactions to inducible regulation of
gene expression in living organisms [11]. It is also important to
underline that inducible homodimerization, mostly by employing
derivatives of FK1012, is an important and widely used tool in
chemical biology. For a broader overview on CID applications,
please consult recent reviews on the topic [6,12,13] and the com-
prehensive list of publications available on the website of the com-
mercial supplier for dimerizer technology [11]. The main focus ofA B
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Fig. 1. Structure of rapamycin (A) and (B) rapamycin bound to itsthis review is the use of inducible heterodimerization to modulate
cell signaling in an acute and highly precise manner.
3. Dimerizer-induced modulation of cellular signal
transduction
The ﬁeld of signal transduction is particularly attractive for
applying tools that speciﬁcally manipulate single enzyme activities
in living cells. Typically enzyme inhibitors or, more rarely, activa-
tors are used. However, CIDs provide a good alternative to rapidly
modulate enzyme activity. This offers the possibility to trigger sig-
naling events downstream of the plasma membrane receptor level
and permits to dissect signaling networks, because only one spe-
ciﬁc branch of the network is activated. By using several orthogo-
nally acting chemical dimerizers simultaneously, it might become
possible in the future to reconstitute even fairly complex signaling
patterns.
Fig. 2 depicts a typical approach that involves the translocation
of a constitutively active form of a protein of interest (POI) to the
plasma membrane. If the protein is an enzyme and ﬁnds its sub-
strate exclusively at the plasma membrane, no activity will be ob-
served as long as enzyme and substrate are physically separated.
After translocating the enzyme to the plasma membrane, the en-
zyme–substrate complex is formed successfully and the signal is
triggered. One of the possible protein families especially amenable
to such manipulations are G proteins. The availability of both con-
stitutively active (GTPase deﬁcient) and dominant negative (inca-
pable of productive interaction with GTPase activating proteins
(GEFs)) makes them convenient targets for the dimerizer-inducible
approach [14–17]. Another group of important proteins which was
shown to be successfully manipulated in this way are enzymes in-
volved in the metabolism of membrane lipids, especially phospho-
inositides [18–22]. The physical separation of (mislocalized)
cytoplasmic enzymes and its substrate at the membrane makes it
theoretically easy to construct an inducible tool.
Indeed, the list of currently available rapamycin-inducible sig-
naling molecules contains numerous examples of proteins belong-
ing to these groups (Table 1). Established CID-dependent tools
cover a large fraction of the cellular signaling modules, ranging
from small G-proteins, heterotrimeric G-protein subunits, phos-
phoinositide metabolizing enzymes, receptor- and non-receptor
tyrosine kinases, serine/threonine protein kinases to transmem-
brane receptors without enzymatic function and signaling adapter
proteins.
Without doubt, the most commonly used CID-dependent
molecular tool is the rapamycin-inducible phosphatidylinositol
4,5-bisphosphate [PtdIns(4,5)P2] 5-phosphatase. It was indepen-N
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Fig. 2. Generic application of rapamycin induced translocation in living cells. One of
the rapamycin binding domains (here FRB) provides an anchor at the desired site of
action of the protein of interest (POI), which itself is expressed as a cytoplasmic
fusion with the second rapamycin binding domain (here FKBP). Upon addition of
rapamycin to the cells, the compound diffuses through the plasma membrane and
ﬁrst binds to FKBP. Then, the rapamycin–FKBP complex binds to FRB. Within
seconds after addition of rapamycin, the POI construct translocates to the site
where the FRB domain resides (here the plasma membrane). In case the POI has an
intrinsic enzyme activity, this will be carried to the membrane where the respective
enzyme substrate resides. Cyan and red circles represent ﬂuorescent proteins,
which may be added to allow monitoring and quantiﬁcation of the translocation
event.
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bias Meyer [19] and since then has been used to study the role of
PtdIns(4,5)P2 on diverse cellular processes, e.g. store-operated cal-
cium entry (SOCE) [50,51], endocytosis [52,53], peripheral mem-
brane proteins targeting [54], regulation of activity of ion
channels [55,56] or studies of PTEN (phosphatase and tensin
homologue deleted on chromosome 10) activation mechanism
[57]. Also, rapamycin-inducible phosphoinositide 3-kinase has
provided an elegant tool to study various aspects of cell biology
[19,58–60]. It can be anticipated that the novel tools by the group
of Takanari Inoue for inducing elevated PtdIns(4,5)P2 levels [19,20]
will be equally appreciated by the scientiﬁc community.
In addition to the plasma membrane, effective dimerizer-
dependent recruitment of signaling components and concomitant
modulation of cell signaling is possible at other intracellular
locations. Good examples of such applications are provided by
CID-inducible depletion of the endosomal phosphatidylinositol
3-phosphate (PtdIns3P) pool [18,22] or inducible degradation of
phosphatidylinositol 4-phosphate (PI4P) within the membranes
of the Golgi apparatus [42].
Chemically controlled activation of monomeric G-proteins has
for long time been referred to as one of the benchmark applications
of the CID technology. As mentioned above, selective activation of a
given small GTPase is achieved by membrane translocation of a
constitutively active GTPase mutant (while inactivation can be
achieved by translocating a dominant negative form of the G-pro-
tein) [14–17]. Another possible approach for inducible activation ofmonomeric G-proteins relies on the translocation of their cognate
guanine nucleotide exchange factors (GEFs) [16,20,40,41]. The lat-
ter mode of stimulation assures physiologically relevant activation
levels (only endogenously available amounts of the G-protein can
be activated), as it does not require over-expression of the mutated
G-protein isoforms. Currently, various small GTPases of the Rho,
Ras and Arf families have been successfully activated by chemical
dimerizers [14–17,20,40,41] and it is plausible that inducible acti-
vation of other monomeric G-proteins could be achieved in a sim-
ilar manner. Surprisingly, the group of heterotrimeric G-proteins,
an important family of intracellular signal transducers, has joined
the set of the rapamycin-inducible signaling molecules only re-
cently [39]. Gaq and Gas, crucial mediators of cellular calcium
and cAMP signaling, respectively, have been successfully activated
by induced plasma membrane recruitment. Also Gb1c2 heterodi-
mers have been shown to possess independent signaling functions
by affecting intracellular calcium transients [39]. Interestingly,
rapamycin-dependent Gbc dimers have been previously reported
in the literature. Inducible recruitment of the heterodimer to the
Golgi membranes was used to study Gbc effects on the integrity
of this organelle [61], but not to assess Gbc signaling competence
at the plasma membrane, the major site of action of heterotrimeric
G-proteins.
Engineered kinase alleles which can be allosterically activated
by rapamycin and its analogues were introduced by the group of
Klaus Hahn and constitute another recent addition to the palette
of CID-dependent tools for manipulating cellular signal transduc-
tion [29]. Inducible activation of different serine/threonine and
tyrosine protein kinases (FAK (focal adhesion kinase), Src and
p38) was achieved by inserting an engineered FKBP variant into
the kinase catalytic domain. Upon addition of rapamycin, binding
of inserted FKBP and co-expressed FRB molecule resulted in selec-
tive activation of the engineered kinase constructs. This approach
to inducible activation does not require translocation of the ini-
tially mislocalized protein constructs, thus the modiﬁed kinase is
activated at its endogenous intracellular location. The generic nat-
ure of this method holds the promise that other kinases are also
amenable to such a form of activation. Importantly, the exploratory
value of these novel tools is even more enhanced by further devel-
opments of Hahn and co-workers, namely caged rapamycin deriv-
atives and light-induced activation of kinase constructs [62] (see
below).4. Further applications of inducible heterodimerization
Among the plethora of applications for inducible heterodimer-
ization and related techniques, there are many that do not rely
on the acute and selective activation of signal transduction path-
ways. However, many of these applications provide very important
tools for studying/manipulating various aspects of cell biology and
have direct repercussions on the intracellular signal transduction.
Below selected examples of such applications are described. A
more complete overview on CID-related techniques is available
elsewhere [11–13].
Conditional protein splicing developed in the group of Tom Muir
is one of the prominent methods to achieve post-translational acti-
vation of protein constructs [63–66]. The protein of interest can be
divided into two separate polypeptides, each expressed as a sepa-
rate fusion with one of the rapamycin binding domains (FKBP or
FRB). These fusions are additionally equipped with one of the
two fragments of a split intein. In the presence of the heterodimer-
izer, binding of FKBP and FRB induces proximity of the two intein
fragments resulting in the formation of a functional intein and
leading to protein splicing. The latter allows covalent linkage of
the two parts of the protein of interest and reconstitutes the
Table 1
Overview of the CID-dependent signaling modules.
Protein target Site of action POI construct Membrane anchor Monitored event Referen-ces
Akt PM FRB-Akt2 [23]
3xFKBP-Akt1 DPH [24,25]
PMSrc-2xFKBP
[23] PMSrc-2xFRB [24,25]
Akt/PKB activation [23–25]
c-Abl
Fyn
Lck
Lyn
PM PMc-Abl-2xFKBP-c-Abl [26]
FKBP-FynD527-533 [27]
FKBP-Lck Y505F [27]
FKBP-Lyn Y508F [27]
–
PMSrc-3xFKBP [27]
NRTK activation [26]
[27]
[27]
[27]
b-Arrestin 2 GPCR and PM FRB-b-arrestin 2 V1aR/V2R-FKBP
PMSrc-2xFKBP
GPCR internalization, ERK activation [28]
FAK, Src, p38a Endogenous location Variant of FKBP inserted into catalytic domain of respective kinase – Kinase activation [29]
Fas PM PMSrc-1/2/3xFKBP-FasCD [30,31]
PMSrc-3xCyP-FasCD [32]
– Fas activation, induction of apoptosis [30–32]
FGFR
FGFR
ErbB
c-Kit
PDGFR
IR
PM PMSrc-FGFR1/2CD-2xFKBP [33]
PMSrc-FKBP-FGFR1CD [34]
p75ED+TM-ErbB1/2CD-FKBP/FRB [35,36]
PMSrc-3xFKBP-c-KitCD [37]
PMSrc-3xFKBP-PDGFRCD [38]
PMSrc-3xFKBP-IRbCD [38]
– RTK activation by homo- and heterodimerization [33]
[34]
[35,36]
[37]
[38]
[38]
Gaq, Gas, Gb1c2 PM FKBP-Gaq C9S, C10S, Q209L
FKBP-Gas
Gb1c2-FKBP
PMLck-FRB Intracellular calcium and cAMP signaling [39]
Myotubularin 1 Endosome FRB-myotubularin 1 2xFKBP-Rab5a Depletion of endosomal PtdIns3P pool [18,22]
PH domain of PLCd PM/mt FKBP-PH PLCd FRB-TMMoA* Unmasking of PtdIns4P at the PM [20]
PI3K PM FKBP-p85 PI3K(aa420-615) PMLyn-FRB PtdIns(3,4.5)P3 synthesis [19]
PI4P5K PM FKBP-PI4P5KIc(aa1-635) S264A R445E K446E PMLyn-FRB Synthesis of PtdIns(4,5)P2 from PtdIns4P [19,20]
PtdIns(4,5)P2 5PTase PM FKBP-Inp54p(aa1-331) [19]
FKBP-INPP5E(aa214-644) C641A [21]
PMLyn-FRB [19]
PMGAP43-FRB [21]
Depletion of the PM PtdIns(4,5)P2 pool [19,21]
Rac1
Rac2
Tiam1
Cdc42
Cdc42
RhoA
PM Rac1 G12 V-FRB [14]
FKBP-Rac1/2(DCAAX) Q61L [16]
FKBP-Tiam1(aa1012-1591) [16]
Cdc42 G12 V-FRB [15]
FKBP-Cdc42(DCAAX) Q61L [16]
FKBP-RhoA(DCAAX) Q63L [16]
CD25ED+TM-2xFKBP [14,15]
PMLyn-FRB [16]
Small G-protein activation/inactivation, PM protrusions [14,16]
[16]
[16]
[15]
[16]
[16]
Ras
Sos
PM FKBP-RasGRF(aa1003-1273) [40]
3xFKBP-Sos1 [41]
PMLyn-FRB [40]
PMSrc-3xFKBP [41]
Ras activation, PM rufﬂes, ERK activation [40]
[41]
Rem PM FKBP-Rem(aa2-265) PMLyn-FRB Inactivation of CaV channels [17]
Sac1 Golgi FKBP-Sac1(aa2-516) Tgn38-FRB Depletion of PI4P pool at the Golgi [42]
Sec7 (Arf6 GEF) PM FKBP-Sec7(ArfGEF domain) PMLyn-FRB Induction of endocytosis [20]
STIM1 ER FRB/2xFKBP replacing EF-hand and SAM domains of STIM1 [43]
FKBP-STIM1(aa238-685) [44]
–
Sac1(aa521-587)-FRB [44]
Activation of SOCE [43]
[44]
TCRf PM PMSrc-TCRfCD-3xFKBP – T cell receptor activation [45,46]
TGF-bRI, TGF-bRII PM Inter alia:
PMSrc-FKBP-TGF-bRICD,
FRB-CyP-TGF-bRIICD
– Smad activation, cell growth inhibition [47,48]
VAMP2/synaptobrevin Presynaptic vesicles VAMP2-2xFKBP – Inhibition of synaptic transmission [49]
WASP PM FRB-WASP DPH CD25ED+TM-2xFKBP PM protrusions [15]
Abbreviations used: cAMP – cyclic adenosine monophosphate, CD – cytoplasmic domain, CyP – cyclophilin, ED – extracellular domain, ER – endoplasmic reticulum, ERK – extracellular signal-regulated kinase, FAK – focal adhesion
kinase, FGFR – ﬁbroblast growth factor receptor, GEF – guanine nucleotide exchange factor, GPCR – G-protein-coupled receptor, IR – insulin receptor, IRb – insulin receptor b chain, MoA – monoamine oxidase, mt – outer
mitochondrial membrane, NRTK – non-receptor tyrosine kinase, PDGFR – platelet-derived growth factor receptor, PH – pleckstrin homology, PI3K – phosphoinositide 3-kinase, PI4P – phosphatidylinositol 4-phosphate, PI4P5K –
phosphatidylinositol 4-phosphate 5-kinase, PKB – protein kinase B, PLC – phospholipase C, PM - plasma membrane/plasma membrane targeting peptide, PtdIns(3,4,5)P3 – phosphatidylinositol 3,4,5-trisphosphate, PtdIns(4,5)
P2 – phosphatidylinositol 4,5-bisphosphate, PtdIns(4,5)P2 5PTase – phosphatidylinositol 4,5-bisphosphate 5-phosphatase, PtdIns3P – phosphatidylinositol 3-phosphate, RTK – receptor tyrosine kinase, SAM – sterile alpha motif,
SOCE – store-operated calcium entry, STIM1 – stromal interaction molecule 1, TCR – T cell receptor, TGF-bRI/II –transforming growth factor b receptor I/II, TM – transmembrane domain, V1aR – vasopressin receptor type 1a,
V2R – vasopressin receptor type 2, VAMP2 – vesicle-associated membrane protein 2, WASP – Wiskott–Aldrich syndrome protein.
* Detailed design of the construct not described.
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fashion.
Another approach to regulate protein function by the Muir
group addresses the regulation of protein stability by reconstitution
of a split ubiquitin (Ub) molecule [67]. In this method, called SURF
(split ubiquitin for the rescue of function), the protein of interest is
fused to a split Ub fragment tagged with FRB and a degradation sig-
nal which leads to constitutive proteasomal degradation of the fu-
sion construct. In the presence of the dimerizer and the FKBP
fusion of the second Ub fragment, the functional Ub molecule
forms. Upon cleavage by endogenous deubiquitinating enzymes,
the protein of interest becomes released from the degradation sig-
nal and stays intact. There are numerous other methods to regulate
protein stability/degradation in a chemically-controlled manner
[2–4]. For example, inducible protein degradation was achieved
by rapamycin-dependent targeting of proteins to the subunits of
the yeast proteasome [68]. In another method, the protein of inter-
est was fused to a destabilizing variant of the FRB domain, which
promoted constitutive degradation of the entire fusion construct.
In this system, the protein of interest is inducibly stabilized upon
dimerizer/FKBP binding [69,70]. Yet another approach, developed
by Tom Wandless and collaborators, relies on mutated variants
of FKBP, which, upon fusion to the protein of interest, inﬂuence
the stability of the construct. Depending on the particular variant
of the method, addition of the small molecule ligand of FKBP leads
either to construct stabilization [71,72] or degradation [73].
A novel method for inducible inactivation of proteins on a time
scale of seconds to minutes is provided by the so-called anchor-
away approach. When applied in yeast, this technology led to rap-
amycin-induced trapping of nuclear proteins (fused to FRB) in the
cytoplasm, by complexing it with the FKBP-tagged large ribosomal
subunit [74]. Another variant of the anchor-away approach for ra-
pid inducible protein inactivation was applied in HeLa cells [75]:
the endogenous pool of the protein of interest, in this case adaptor
protein-1 and -2 (AP-1/2), was depleted by siRNA and, simulta-
neously, the knock-down resistant copies of the protein were ex-
pressed as FKBP fusions. When FRB domains were expressed on
the surface of the outer mitochondrial membrane, addition of rap-
amycin caused fast inactivation of the protein of interest by its re-
routing to the mitochondrial membrane, resulting in impaired
intracellular vesicle trafﬁcking. Due to its speed of action, which
minimizes the risk of compensatory mechanisms, the anchor-away
technique, although relatively cumbersome, may present a valu-
able alternative to standard protein knock-down by siRNA. It is
worth noting that the recently described method of inducible lib-
eration of phosphatidylinositol 4,5-bisphosphate at the plasma
membrane principally relies on the anchor-away approach [20].
Inducible regulation of nuclear trafﬁcking is closely related to
CID-dependent re-routing of intracellular proteins within the
anchor-away method. Until now, rapamycin-induced nuclear im-
port/export has been most meticulously studied in yeast [76–78],
although reports on its application in mammalian cultured cells
are also available [79–81]. In both cases, induced shuttling of
proteins from the nucleus to the cytoplasm (or vice versa) is a rel-
atively slow process, requiring tens of minutes until the steady
state is reached [76,79,80]. This most probably relates to the
endogenous kinetics of nuclear trafﬁcking. Nevertheless, inducible
nuclear translocation of proteins constitutes a valuable tool, which
could be used for example to study DNA replication, transcription,
or DNA repair.
The reversible aggregation approach takes advantage of the FKBP
F36M mutant, which has the tendency to spontaneously dimerize
in the absence of its cognate ligand (AP21998, a synthetic rapamy-
cin mimic) [82]. Thus, protein fusions equipped with several copies
of FKBP F36M tend to create macromolecular clusters, which can
be reversibly solubilized by addition of the drug. Notably, thisapproach has been adapted to trigger protein secretion, which
was induced by drug-evoked disruption of molecule clusters with-
in the endoplasmic reticulum [11,83,84].
5. Effects of rapamycin on cell function and the use of rapalogs
As already mentioned, rapamycin is an immunosuppressant in
that it potently inhibits TORC1, an important protein kinase in-
volved in numerous aspects of cell biology such as cell growth, pro-
liferation and regulation of autophagy [7,85]. Therefore,
application of rapamycin in cellulo or in vivo may have pleiotropic
detrimental effects on the living system under investigation [7]. In
some applications in cultured cells, the short experiment time may
justify application of rapamycin, as it takes usually longer periods
of time to unravel its potential toxic effects. Otherwise, application
of non-toxic synthetic rapamycin analogues (so-called rapalogs)
may be highly advisable. Rapalogs (Fig. 3) have been created by
using the ‘bump-and-hole’ approach [6,86]. The part of rapamycin
skeleton which is responsible for binding of the endogenous FRB
domain of TOR becomes equipped with a bulky substituent (the
‘bump’), which abolishes any binding to wild type FRB. In order
to restore the dimerizing potency of such a modiﬁed molecule, a
heterologously expressed FRB domain contains mutations which
enlarge its rapamycin-binding pocket (the ‘hole’) to accommodate
the bump. As a result, the rapalog molecule is devoid of inhibitory
effects towards TOR kinase, but still readily induces dimerization
of FKBP and the mutated FRB domain. There are several examples
of different rapalogs in the literature (Fig. 3) [6,16,78,81], with the
most popular compound AP21967 being commercially available. It
is important to note that particular care must be taken while syn-
thesizing and purifying rapalogs in house, since even minute con-
tamination with rapamycin causes extensive inhibition of TOR
kinase [87]. Interestingly, the toxicity of rapamycin is not a big
obstacle for applications in yeast, since there are rapamycin-insen-
sitive strains with TOR mutations and deleted endogenous FKBP12
[74,78].
6. Reversibility and caged rapamycin
Because of the high afﬁnity of rapamycin towards its protein
binding partners (Kd = 0.2 nM for rapamycin–FKBP binding and
Kd = 12 nM for FKBP-rapamycin-FRB [88]), rapamycin-inducible
tools for manipulating signal transduction can be considered irre-
versible (in cellulo), even though in some cases out-competing
FKBP binding to rapamycin by high concentrations of FK506 is at-
tempted, usually with relatively moderate success (e.g. [89]).
Recent advances in the rapamycin-inducible protein dimeriza-
tion technique allow both high temporal and increased spatial con-
trol of the activated event. This can be achieved by applying caged
rapamycin, i.e. rapamycin molecules equipped with a photo-labile
substituent. Ideally, after applying caged rapamycin onto cells, the
presence of the substituent should prevent effective dimerization
between FRB and FKBP domains. Local and brief illumination with
light would release the functional dimerizer, thus inducing the
FRB–FKBP interactions only in the illuminated region. Currently
available caged dimerizers do not fulﬁll these ideal expectations
yet, but nevertheless constitute a big step in this direction. cRb,
developed in the lab of Takanari Inoue [90], features a nitrobenzyl
cage linked to HE-Rapa, a rapamycin analogue which, just as its
parental molecule, is a potent dimerizer of FRB and FKBP proteins
(Fig. 4A). The cage connects the dimerizer with a biotin molecule.
Unfortunately, cRb was still able to induce interactions between
FRB and FKBP, indicating that the steric hindrance of biotin and
the nitrobenzyl cage was insufﬁcient to prevent FRB–FKBP hetero-
dimerization. However, incubation of cRb with avidin prior to its
application onto cells resulted in trapping of the dimerizer in the
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diation with light. After local illumination of the cell boundary
with UV light, dimerizer-induced plasma membrane rufﬂe forma-
tion (by activation of CID-dependent Rac1 GEF) was observed,
mostly restricted to the vicinity of the irradiated area of the cell.
While an elegant solution to the problem of ‘leaky’ rapamycin
derivatives, this approach to spatial control of CID-regulated
events has a few limitations. Most of all, its application may be re-
stricted to events happening at the plasma membrane. In addition,
diffusion of the light-liberated dimerizer may hinder attempts to
induce dimerization in a highly spatially restricted manner.
In an alternative approach, Hahn and co-workers expanded the
concept from CID-regulated protein kinases [29] to light-inducible
ones [62]. pRap consists of a rapamycin molecule, linked at its C40
position to a nitrobenzyl photo-cage (Fig. 4B). Interestingly, in this
case the steric obstacle was sufﬁcient to inhibit binding of FRB and
engineered FKBP (iFKBP, inserted into the catalytic domain of FAK).
Upon illumination with UV light, pRap released rapamycin which
effectively activated the inducible kinase construct. However, until
now pRap has not been demonstrated to be activatable with
sub-cellular spatial resolution. Moreover, for both novel caged rap-
amycin derivatives (i.e. cRb and pRap) no thorough analyses were
performed of how modiﬁcations of the rapamycin skeleton inﬂu-
ence the membrane permeability of the respective compounds. It
is conceivable that the caged species exhibit much reduced poten-
tial of diffusing through the lipid bilayer. Then, at least to some
extent, uncaging would simply serve to release molecules which
cross the plasma membrane more readily, rather than to remove
the steric hindrance of FRB–FKBP binding. Certainly, more work
is needed to fully establish reliable caged dimerizers. Their poten-
tial use in vivo by applying two-photon uncaging should provide a
sufﬁcient compensation for the signiﬁcant synthetic effort.
7. Alternative chemical dimerizers
While rapalog-based dimerization approaches hold great prom-
ise for manipulating cell function, the methods still have limita-
tions. For instance, despite the proven selectivity of certain
rapalogs towards particular mutants of the FRB domain [81], to
our knowledge there are no communications on successful applica-
tion of two different rapamycin derivatives simultaneously in the
same cell for regulating two processes in an orthogonal fashion.
Such an approach would require using FKBP as a universal anchor
for protein translocation, and two different FRB domain mutants
within the independently translocatable fusion constructs. A truly
orthogonal solution could probably be best provided by using CIDs
that employ totally different molecular components such as SNAPtag [91] or beta-lactamase fusions [92,93]. A review of cross-link-
ing alternatives has recently been compiled [94].
An appealing approach to orthogonal chemical dimerizers relies
on engineered natural compounds (and their receptor proteins)
from biological pathways which are distinct from the ones present
in animal cells. Recent reports describe application of two different
plant hormones which successfully act as inducers of dimerization.
In one promising example, engineering of the abscisic acid (ABA)
signaling pathway resulted in the development of a novel hetero-
dimerizer, with a structure completely unrelated to rapamycin
(Fig. 4C) [95]. As a matter of fact, ABA was used concomitantly with
rapamycin in a truly orthogonal fashion. However, in the current
design of this novel heterodimerization system, the ABA-induction
kinetics seems to be severely inferior to the one of rapamycin and
its analogues. Another new example of a similar strategy comes
from Miyamoto and colleagues [96], who adopted the plant hor-
mone gibberellin (GA3) as an inducer of dimerization. To circum-
vent the problems of membrane permeability of GA3, its
negatively charged carboxyl group was masked by an acetoxy-
methyl (AM) group, resulting in GA3-AM (Fig. 4D). Once in the
cytoplasm, the protecting AM group is readily hydrolyzed by
endogenous esterases, thus liberating a functional dimerizer mole-
cule. Application of GA3-AM onto cells resulted in rapid (compara-
ble to the speed of action of rapamycin) dimerization of engineered
gibberellin binding proteins. Moreover, rapamycin and GA3-AM
were shown to act independently from each other, enabling precise
and timely control of two different intracellular events within a
single living cell. With this quite spectacular achievement, chemi-
cal biology is approaching a fascinating possibility of constructing
complex artiﬁcial signaling networks in cellulo and in vivo. Analy-
sis of the biological outcome will certainly shed new light on
endogenous signal transduction mechanisms.
8. Limitations and future developments
During the past decade, the chemical dimerizer concept has
emerged as a truly orthogonal technique for manipulating enzyme
activity in living cells. The truth is, however, that it is only used by
a handful of labs because the cloning effort is fairly high and the
constructs are not readily available. For this reason, it would be
beneﬁcial to have generally available stably transfected cell lines
featuring, for instance, rapamycin-binding domains as mem-
brane-targeted constructs.
So far, one of the limitations when using rapamycin, rapalogs
or even caged rapamycin derivatives is the lack of switching off the
signal, as rapamycin is practically not released from its binding pro-
teins. It would therefore be fascinating to have a photo-destructable
UVA
apaR-EHbRc
O
O
MeO
O
O
N
O
O
O
HO
MeO
OMe
OH
O
O
NO2
O
O N
N
N S
HN
NH
H
H
O
O
O
MeO
O
O
N
O
O
O
HO
MeO
OMe
OH
O
OH
B
pRap
O
O
MeO
O
O
N
O
O
O
HO
MeO
OMe
OH
O
O O
O
O
NO2
C
ABA
(S-(+)-abscisic acid)
O
OH
O OH
D
GA3-AM
HO
H
O O
O
O
OH
O
H
Fig. 4. Latest improvements in the heterodimerizer technology. Photoswitchable rapamycin derivatives (A) cRb, which upon UV irradiation releases HE-Rapa and (B) pRap,
which after photo-uncaging produces rapamycin. (C) ABA and (D) GA3-AM, truly orthogonal chemical dimerizers. For details see main text.
M. Putyrski, C. Schultz / FEBS Letters 586 (2012) 2097–2105 2103version that would permit the generation of transient signaling
patterns mimicking those observed in intact cells.
The largest impact, however, would have the generation of new
orthogonal chemical dimerizers and their use in a physiologically
relevant model system. The fully independent activation of several
branches of a signaling network in a time-dependent fashionwould
open new doors for studying the crosstalk of signaling elements.
9. Conclusion
Chemical dimerizers such as rapamycin are some of the few fast
acting molecules that can be combined with genetically encoded
signaling components, meaning that enzymes may be activated
independently of a ligand designed to bind the enzyme. This
complements the artiﬁcial activation of signaling molecules bymembrane-permeant allosteric enzyme activators such as second
messenger mimics [97]. The combinatorial use of these fast acting
tools will be essential to unravel complex intracellular networks
and for validating models produced by systems biology efforts in
the future.
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